Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ZED-1227 by Zedira for Celiac Disease: Likelihood of Approval
ZED-1227 is under clinical development by Zedira and currently in Phase II for Celiac Disease. According to GlobalData, Phase II...
Data Insights
ZED-1227 by Zedira for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
ZED-1227 is under clinical development by Zedira and currently in Phase I for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). According...